The National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC) are seeking proposals for improved diagnostic assays for measles, mumps, rubella, and varicella. The goal is to develop diagnostic tools that can rapidly confirm the presence of these pathogens and guide public health responses. The Phase I SBIR proposals will be accepted, with a budget of up to $243,500 for up to 6 months. Phase II proposals can receive up to $1,972,828 and have a duration of up to 2 years. The deadline for proposal submission is November 14, 2023.